Talc Pleurodesis for Malignant Pleural Effusion on Outpatient Basis

This clinical trial investigates whether a procedure known as talc pleurodesis can be effectively performed on an outpatient basis for patients with malignant pleural effusion, which is a condition where fluid builds up around the lungs due to cancer. By performing the procedure outside of the hospital, the study aims to make treatment more convenient for patients and potentially reduce hospital stays and associated costs. The trial targets patients who are eligible for this procedure and offers them a chance to participate in the study in addition to receiving standard care options. During the study, participants undergo a process starting on the first day where a chest drain is inserted to remove fluid from the chest cavity. The fluid is drained in stages throughout the day, and patients go home with a special bag to collect any remaining fluid. On the second day, if the fluid removal is successful and the lung is fully expanded, talc is introduced into the chest to prevent fluid from accumulating again, and the process of draining and monitoring continues. By the third day, if the fluid accumulation has resolved, the drain is removed, and the success of the procedure is confirmed with a chest x-ray. Participants are also asked to fill out short questionnaires regarding their breathing, pain levels, and overall satisfaction with the procedure, which helps measure the trial's success.